Since its foundation in 2012, Plexense, Inc. has specialized
in the development and production of rapid and cost-effective
immunoassay platform for clinical, agricultural and biological testing.
Our proprietary technology, ACCEL ELISA®, provides up to
40X increase in sensitivity compared to conventional techniques.
Plexense, Inc. has been working as development and
collaboration partners with Mayo Clinic, the US Department
of Agriculture (USDA) – ARS, the Korea Center for Disease Control (KCDC) and the Korea Research Institute of Bioscience and Biotechnology (KRIBB) to develop
advanced early diagnostic kits utilizing its proprietary
ACCEL ELISA® technology.
Plexense, Inc. headquartered in Korea with
primary R&D and production in Korea, as well.
It also has an affiliate company under the name
Plexense BIO, Inc. in California and Florida, USA.
#B-604, 670 Daewangpangyo-ro, Bundang-gu,
Republic of Korea, 13494
#1-1301, 1302, 1303, 16-4 Dongbaekjoongang-ro
16 beongil, Giheung-gu, Yongin-si, Gyeonggi-do,
Republic of Korea, 17015
Plexense BIO, Inc.
4136E Commerce Way, Suite 300,
Sacramento, CA 95834 USA